These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 15265246)
1. Quetiapine in schizophrenia: onset of action within the first week of treatment. Small JG; Kolar MC; Kellams JJ Curr Med Res Opin; 2004 Jul; 20(7):1017-23. PubMed ID: 15265246 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials. Buckley PF Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183 [TBL] [Abstract][Full Text] [Related]
3. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS; Konarski JZ; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773 [TBL] [Abstract][Full Text] [Related]
4. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Vieta E; Mullen J; Brecher M; Paulsson B; Jones M Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892 [TBL] [Abstract][Full Text] [Related]
5. Quetiapine has a direct effect on the negative symptoms of schizophrenia. Tandon R Hum Psychopharmacol; 2004 Dec; 19(8):559-63. PubMed ID: 15486960 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. Lee KU; Jeon YW; Lee HK; Jun TY Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454 [TBL] [Abstract][Full Text] [Related]
7. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned. Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151 [TBL] [Abstract][Full Text] [Related]
8. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196 [TBL] [Abstract][Full Text] [Related]
9. The effect of quetiapine on aggression and hostility in patients with schizophrenia. Arango C; Bernardo M Hum Psychopharmacol; 2005 Jun; 20(4):237-41. PubMed ID: 15830402 [TBL] [Abstract][Full Text] [Related]
10. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
11. The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study. Lindenmayer JP; Brown D; Liu S; Brecher M; Meulien D Psychopharmacol Bull; 2008; 41(3):11-35. PubMed ID: 18779774 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR; J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817 [TBL] [Abstract][Full Text] [Related]
13. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study. Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848 [TBL] [Abstract][Full Text] [Related]
14. Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies. Suppes T; Hirschfeld RM; Vieta E; Raines S; Paulsson B World J Biol Psychiatry; 2008; 9(3):198-211. PubMed ID: 17853277 [TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387 [TBL] [Abstract][Full Text] [Related]
16. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Arvanitis LA; Miller BG Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900 [TBL] [Abstract][Full Text] [Related]
17. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep. Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180 [TBL] [Abstract][Full Text] [Related]
18. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania. Ketter TA; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011 [TBL] [Abstract][Full Text] [Related]
19. Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia. Kasper S Depress Anxiety; 2004; 20(1):44-7. PubMed ID: 15368596 [TBL] [Abstract][Full Text] [Related]
20. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. Cookson J; Keck PE; Ketter TA; Macfadden W Int Clin Psychopharmacol; 2007 Mar; 22(2):93-100. PubMed ID: 17293709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]